SLIDESHOW: 10 Stocks Crossing Below Their 200 Day Moving Average

(1) Notable Two Hundred Day Moving Average Cross - BLUE triggered: 06/22/2018

bluebird bio is a clinical-stage biotechnology company committed to developing potentially transformative gene therapies for severe genetic diseases and cancer. Co.'s clinical programs in severe genetic diseases include its LentiGlobin® product candidate as a treatment for transfusion-dependent ß-thalassemia, and severe sickle cell disease, or severe SCD, and its Lenti-D™ product candidate as a treatment for cerebral adrenoleukodystrophy, a rare hereditary neurological disorder. bb2121 and bb21217, Co.'s primary product candidates in oncology, are CAR T cell product candidates for the treatment of multiple myeloma.

BLUE — Key Stats (updated Friday, June 22, 10:22 AM)

Name:  bluebird bio Inc Website:  www.bluebirdbio.com Sector:  Biotechnology Number of ETFs Holding BLUE:  26 (see which ones) Total Market Value Held by ETFs:  $539,077,161 Total Market Capitalization:  $9,177,000,000 % of Market Cap. Held by ETFs:  5.87%

Read full article in a new window: Notable Two Hundred Day Moving Average Cross - BLUE

Open the BLUE Videos Page (in a new window) »

BLUE — Current Quote

Quotes delayed 20 minutes

Avg. Broker Rec.

Buy (3.20 out of 4) 54th percentile (ranked higher than approx. 54% of all stocks covered) Based on data provided by Zacks Investment Research via Quandl.com

Featured Slideshows

Warren Buffett Energy Stocks The Top 10 DividendRank'ed Stocks The DividendRank Top 25 The Top 10 DividendRank'ed DJIA Components The Top 10 DividendRank'ed Dow Transports Components The Top 10 DividendRank'ed Dow Utilities Components The Top 10 DividendRank'ed Nasdaq 100 Components 10 Stocks Going Ex-Dividend 10 Oversold Dividend Stocks 10 Stocks Where Yields Got More Juicy 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did Top Ranked Dividend Stocks With Insider Buying 10 ETFs With Stocks That Insiders Are Buying 25 Dividend Giants Widely Held By ETFs 25 S.A.F.E. Dividend Stocks Increasing Payments For Decades Broker Darlings: Top 15 Analyst Picks of the Dow Top 25 Broker Analyst Picks of the S&P 500 Forgotten S&P 500 Giants: Analysts' Current Least Favorites Feel-Good Income: 25 Socially Responsible Dividend Stocks 10 Energy Stocks You Can Buy Cheaper Than Insiders Did 10 Metals Stocks You Can Buy Cheaper Than Insiders Did 10 Oversold Metals Stocks 10 Must-Know High-Yield REITs 10 Top DividendRank'ed Financials 10 Top DividendRank'ed Metals Stocks 10 Oversold Energy Stocks 10 Top DividendRank'ed Energy Stocks 10 Top DividendRank'ed Utility Stocks 10 Stocks Crossing Below Book Value 10 Stocks Crossing Above Their 200 Day Moving Average 10 Stocks Crossing Below Their 200 Day Moving Average 10 Energy Stocks Crossing Above Their 200 DMA 10 Energy Stocks Crossing Below Their 200 DMA The 10 Biggest ETFs The 10 Best ETF Performers The 10 Worst ETF Performers 10 ETFs With Notable Inflows 10 ETFs With Notable Outflows Top 10 Analyst Rated Consumer Stocks Top 10 Analyst Rated Dividend Stocks Top 10 Analyst Rated Energy Stocks Top 10 Analyst Rated Financial Stocks Top 10 Analyst Rated Healthcare Stocks Top 10 Analyst Rated REIT Stocks Top 10 Analyst Rated Technology Stocks The Top 10 DividendRank'ed Canadian Stocks The DividendRank Canada Top 25 10 Canadian Stocks Going Ex-Dividend 10 Oversold Canadian Stocks 10 Canadian Stocks Where Yields Got More Juicy 10 Must-Know High-Yield Canadian Real Estate Stocks 10 Top DividendRank'ed Canadian Financials 10 Must-Know High-Yield Canadian Energy Stocks 10 Canadian Stocks Crossing Below Book Value 10 Canadian Stocks Crossing Above Their 200 Day Moving Avg 10 Canadian Stocks Crossing Below Their 200 Day Moving Avg Stock market game

Advertise on Energy Stock Channel